Back to search
FDAFDA · Food and drugs·Recall number D-0499-2023

Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC70518-2750-00

Published April 12, 2023 · Recall initiated: March 20, 2023

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
RemedyRepack distributed product to consignees nationwide within the United States
Lot
Lot#: B1630017-040122, Exp. Date 04/30/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card